Загрузка...
Structural basis for polymerase η–promoted resistance to the anticancer nucleoside analog cytarabine
Cytarabine (AraC) is an essential chemotherapeutic for acute myeloid leukemia (AML) and resistance to this drug is a major cause of treatment failure. AraC is a nucleoside analog that differs from 2′-deoxycytidine only by the presence of an additional hydroxyl group at the C2′ position of the 2′-deo...
Сохранить в:
| Опубликовано в: : | Sci Rep |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6107656/ https://ncbi.nlm.nih.gov/pubmed/30140014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-30796-w |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|